NEW YORK, Oct. 13, 2017 -- OrthoPediatrics Corp. (Nasdaq:KIDS), the only medical device company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market in order to improve the lives of children with orthopedic conditions, rang the opening bell at the Nasdaq MarketSite in Times Square today in celebration of its initial public offering (IPO) on The Nasdaq Stock Market.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b65be065-6879-4ee5-95ba-53cd53d683dc
OrthoPediatrics Corp. designs, develops and commercializes innovative orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. They currently serve three of the largest categories in this market, and estimate that the portion of this market that they currently serve represents a $2.5 billion opportunity globally, including over $1.1 billion in the United States. Children’s skeletal anatomy and physiology differs significantly from that of adults, which affects the way in which children with orthopedic conditions are managed surgically. OrthoPediatrics Corp. sells the broadest product offering specifically designed for children with orthopedic conditions.
“OrthoPediatrics Corp. addresses an unmet market need,” said Nelson Griggs, President of the Nasdaq Stock Exchange. “They have developed a deep understanding of the unique nature of children’s clinical conditions and surgical procedures and we are thrilled to work with a company making such disruptive changes in their industry.”
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Information about the company is provided by the company or comes from the company’s public filings and is not independently verified by Nasdaq. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com
MEDIA RELATIONS CONTACT:
|
|
NDAQG


Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



